{
    "id": 1660,
    "name": "malignant pineal area germ cell neoplasm",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        "1663"
    ],
    "termId": "DOID:1660",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03158064",
            "title": "Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 2439,
                    "therapyName": "Durvalumab + Tremelimumab",
                    "synonyms": null
                }
            ]
        }
    ]
}